NCAM1 and COVID-19: We found a decrease in the proportion of CD8+ cells in CD56− but not in the CD56+ T cell subset in the ICU group compared to the HD, which suggests an increased survival ability of the CD56+CD8+ T cells during COVID-19 (Figure 2f,g).